Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

E2805 Renal Cell Carcinoma On-Study Form NCT00326898

- 20/09/2021 - 1 Formulário, 9 Grupos de itens, 50 Elementos de dados, 1 Idioma

Grupos de itens: Header, Data amendment, Patient demographics, History of Disease, Description of Primary Disease, Description of Current Disease, Current Disease Symptoms, MUGA Scanning, Footer Module

E2805 Renal Cell Carcinoma On-Study Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=053ADDEA-1681-66BC-E044-0003BA3F9857

ECOG-E1505 On-Study Form NCT00324805

- 20/09/2021 - 1 Formulário, 9 Grupos de itens, 56 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Data amendment, Pre-Treatment Characteristics, Patients registered to receive Regimen 4 (Pemetrexed/Cisplatin), Cardiac History, NSCLC Disease Description, Resection Information, Baseline Abnormalities, Comments

ECOG-E1505 On-Study Form NCT00324805 Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=078250FE-30E9-0714-E044-0003BA3F9857

Unknown ECOG Lung Onstudy CRF

- 20/09/2021 - 1 Formulário, 7 Grupos de itens, 42 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Data amendment, Pre-Treatment Characteristics, NSCLC Disease Description, Resection Information, Baseline Abnormalities, Comments

Unknown Onstudy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=109F578D-E5FE-234C-E044-0003BA3F9857

Unknown ECOG Lung Onstudy

- 20/09/2021 - 1 Formulário, 7 Grupos de itens, 42 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Data amendment, Pre-Treatment Characteristics, NSCLC Disease Description, Resection Information, Baseline Abnormalities, Comments

Unknown Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=109F4E7D-3810-226A-E044-0003BA3F9857

E2905 On-Study Form NCT00843882

- 20/09/2021 - 1 Formulário, 5 Grupos de itens, 47 Elementos de dados, 1 Idioma

Grupos de itens: Header, Data amendment, Patient Information, Prior Treatment, Comments

E2905 On-Study Form NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EA9BECA-9DE5-1273-E044-0003BA3F9857

E5103 On-Study Form NCT00433511

- 20/09/2021 - 1 Formulário, 11 Grupos de itens, 48 Elementos de dados, 1 Idioma

Grupos de itens: ECOG clinical trial administrative data, Patient demographics, Performance status, Pre-Registration Evaluation, Pre-Registration Scans/Imaging, Disease Description, Section I - Unilateral Disease - Either Side, Section I - Unilateral Disease - Either Side, Continued, Section II Continued - Complete this section ONLY when reporting Bilateral disease, Section II Continued - Complete this section ONLY when reporting Bilateral disease., Footer Module

E5103 On-Study Form NCT00433511 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=22AFBF9F-D69B-53CC-E044-0003BA3F9857

RTOG-0617 I1: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Initial Evaluation Form NCT00533949

- 20/09/2021 - 1 Formulário, 9 Grupos de itens, 82 Elementos de dados, 1 Idioma

Grupos de itens: Clinical trial administrative data, PRE-TREATMENT CHACTERISTICS, Disease Staging, LYMPH NODE ASSESSMENT, carcinoma of the lung, Required Pretreatment Studies, PET Scan, Pretreatment Labs, Footer

RTOG-0617 I1: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Initial Evaluation Form NCT00533949 High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24AC693F-14F6-1842-E044-0003BA3F9857

CALGB: 90202 On-Study NCT00079001

- 20/09/2021 - 1 Formulário, 10 Grupos de itens, 67 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, INITIAL DIAGNOSIS, PRIOR TREATMENT, CURRENT SUPPLEMENTS, Current Treatment, METASTATIC/RECURRENT SITE(S), Performance Status, LABORATORY VALUES, Footer MODULE

CALGB: 90202 On-Study NCT00079001 Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B4607705-4BBB-0537-E034-0003BA12F5E7

On-Study Form Month 24 Breast Cancer ALTTO BIG 2-06 NCCTG N063D EGF106708 DRKS00003651 NCT00490139 - On-Study Form Month 24 Breast Cancer ALTTO BIG 2-06 NCCTG N063D EGF106708 NCT00490139

- 20/09/2021 - 1 Formulário, 6 Grupos de itens, 33 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Patient Status, Cardiac Monitoring, Hematology and Biochemistry, Radiological examination, Translational Research (Appendix 5)

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=32A2E66F-28A2-0578-E044-0003BA3F9857

E2902 On-Study Form - Form 2050 NCT00093470

- 20/09/2021 - 1 Formulário, 9 Grupos de itens, 42 Elementos de dados, 1 Idioma

Grupos de itens: Header, Evaluation of Disease/Cancer, Current Remission, Current CR Confirmation, Bone Marrow Biopsy/Aspirate, At Any Time, Current Performance Status, Baseline Abnormalities, Comments

E2902 On-Study Form - Form 2050 NCT00093470 Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DBF6D3B9-09FD-06C3-E034-0003BA12F5E7

On-Study Form Week 52 Breast Cancer ALTTO BIG 2-06 NCCTG N063D EGF106708 DRKS00003651 NCT00490139 - On-Study Form Week 52 Breast Cancer ALTTO BIG 2-06 NCCTG N063D EGF106708 NCT00490139

- 20/09/2021 - 1 Formulário, 6 Grupos de itens, 28 Elementos de dados, 1 Idioma

Grupos de itens: Header Module, Patient Status, Cardiac Monitoring, Hematology and Biochemistry, Radiological examination, Translational Research

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=32A2C760-5699-01DF-E044-0003BA3F9857

On-Study Form Advanced Melanoma E2603 NCT00110019

- 20/09/2021 - 1 Formulário, 7 Grupos de itens, 62 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Data amendment, Description of Disease at Initial Diagnosis, History of Disease, Description of Current Disease, Comments

E2603 Advanced Melanoma On-Study Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma E2603 Advanced Melanoma On-Study Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E75E3DD6-DB7A-4ABA-E034-0003BA3F9857

Palavras-chave

Índice

Modelos de dados selecionados